BOIRON SA (BOI.PA) Fundamental Analysis & Valuation

EPA:BOI • FR0000061129

26 EUR
-0.25 (-0.95%)
Last: Mar 13, 2026, 07:00 PM

This BOI.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

Taking everything into account, BOI scores 5 out of 10 in our fundamental rating. BOI was compared to 54 industry peers in the Pharmaceuticals industry. BOI has an excellent financial health rating, but there are some minor concerns on its profitability. BOI has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. BOI.PA Profitability Analysis

1.1 Basic Checks

  • In the past year BOI was profitable.
  • In the past year BOI had a positive cash flow from operations.
  • BOI had positive earnings in each of the past 5 years.
  • Each year in the past 5 years BOI had a positive operating cash flow.
BOI.PA Yearly Net Income VS EBIT VS OCF VS FCFBOI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 3.45%, BOI is doing worse than 61.11% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 5.25%, BOI is in line with its industry, outperforming 40.74% of the companies in the same industry.
  • BOI has a Return On Invested Capital (4.43%) which is comparable to the rest of the industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for BOI is significantly below the industry average of 14.78%.
Industry RankSector Rank
ROA 3.45%
ROE 5.25%
ROIC 4.43%
ROA(3y)4.57%
ROA(5y)4.15%
ROE(3y)6.7%
ROE(5y)6.13%
ROIC(3y)5.61%
ROIC(5y)5.46%
BOI.PA Yearly ROA, ROE, ROICBOI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • Looking at the Profit Margin, with a value of 3.84%, BOI is in line with its industry, outperforming 40.74% of the companies in the same industry.
  • BOI's Profit Margin has declined in the last couple of years.
  • BOI has a worse Operating Margin (5.26%) than 62.96% of its industry peers.
  • BOI's Operating Margin has declined in the last couple of years.
  • BOI's Gross Margin of 73.71% is fine compared to the rest of the industry. BOI outperforms 66.67% of its industry peers.
  • BOI's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 5.26%
PM (TTM) 3.84%
GM 73.71%
OM growth 3Y-32.06%
OM growth 5Y-23.58%
PM growth 3Y-28.17%
PM growth 5Y-20.44%
GM growth 3Y0.74%
GM growth 5Y-0.95%
BOI.PA Yearly Profit, Operating, Gross MarginsBOI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

7

2. BOI.PA Health Analysis

2.1 Basic Checks

  • BOI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for BOI remains at a similar level compared to 1 year ago.
  • BOI has less shares outstanding than it did 5 years ago.
  • BOI has a worse debt/assets ratio than last year.
BOI.PA Yearly Shares OutstandingBOI.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
BOI.PA Yearly Total Debt VS Total AssetsBOI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • An Altman-Z score of 3.56 indicates that BOI is not in any danger for bankruptcy at the moment.
  • BOI has a Altman-Z score (3.56) which is comparable to the rest of the industry.
  • BOI has a debt to FCF ratio of 0.49. This is a very positive value and a sign of high solvency as it would only need 0.49 years to pay back of all of its debts.
  • With an excellent Debt to FCF ratio value of 0.49, BOI belongs to the best of the industry, outperforming 94.44% of the companies in the same industry.
  • BOI has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.04, BOI belongs to the top of the industry, outperforming 87.04% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.49
Altman-Z 3.56
ROIC/WACC0.55
WACC8.12%
BOI.PA Yearly LT Debt VS Equity VS FCFBOI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.3 Liquidity

  • A Current Ratio of 2.39 indicates that BOI has no problem at all paying its short term obligations.
  • BOI has a Current ratio of 2.39. This is in the better half of the industry: BOI outperforms 74.07% of its industry peers.
  • BOI has a Quick Ratio of 1.46. This is a normal value and indicates that BOI is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of BOI (1.46) is better than 74.07% of its industry peers.
Industry RankSector Rank
Current Ratio 2.39
Quick Ratio 1.46
BOI.PA Yearly Current Assets VS Current LiabilitesBOI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

3

3. BOI.PA Growth Analysis

3.1 Past

  • The earnings per share for BOI have decreased strongly by -18.09% in the last year.
  • The earnings per share for BOI have been decreasing by -22.40% on average. This is quite bad
  • The Revenue has been growing slightly by 4.80% in the past year.
  • The Revenue has been decreasing by -2.63% on average over the past years.
EPS 1Y (TTM)-18.09%
EPS 3Y-26.29%
EPS 5Y-22.4%
EPS Q2Q%241.06%
Revenue 1Y (TTM)4.8%
Revenue growth 3Y2.32%
Revenue growth 5Y-2.63%
Sales Q2Q%7.58%

3.2 Future

  • BOI is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.73% yearly.
  • Based on estimates for the next years, BOI will show a small growth in Revenue. The Revenue will grow by 5.54% on average per year.
EPS Next Y5.53%
EPS Next 2Y2.73%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.95%
Revenue Next 2Y1.47%
Revenue Next 3Y8.32%
Revenue Next 5Y5.54%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BOI.PA Yearly Revenue VS EstimatesBOI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M
BOI.PA Yearly EPS VS EstimatesBOI.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4

5

4. BOI.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 23.21, BOI is valued on the expensive side.
  • The rest of the industry has a similar Price/Earnings ratio as BOI.
  • When comparing the Price/Earnings ratio of BOI to the average of the S&P500 Index (25.70), we can say BOI is valued inline with the index average.
  • BOI is valuated reasonably with a Price/Forward Earnings ratio of 11.24.
  • 77.78% of the companies in the same industry are more expensive than BOI, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.84, BOI is valued rather cheaply.
Industry RankSector Rank
PE 23.21
Fwd PE 11.24
BOI.PA Price Earnings VS Forward Price EarningsBOI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 96.30% of the companies in the same industry are more expensive than BOI, based on the Enterprise Value to EBITDA ratio.
  • BOI's Price/Free Cash Flow ratio is rather cheap when compared to the industry. BOI is cheaper than 83.33% of the companies in the same industry.
Industry RankSector Rank
P/FCF 12.24
EV/EBITDA 5.66
BOI.PA Per share dataBOI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)4.2
PEG (5Y)N/A
EPS Next 2Y2.73%
EPS Next 3YN/A

5

5. BOI.PA Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 4.44%, BOI is a good candidate for dividend investing.
  • BOI's Dividend Yield is rather good when compared to the industry average which is at 1.91. BOI pays more dividend than 85.19% of the companies in the same industry.
  • BOI's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 4.44%

5.2 History

  • The dividend of BOI decreases each year by -1.41%.
Dividend Growth(5Y)-1.41%
Div Incr Years0
Div Non Decr Years0
BOI.PA Yearly Dividends per shareBOI.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

5.3 Sustainability

  • 107.57% of the earnings are spent on dividend by BOI. This is not a sustainable payout ratio.
DP107.57%
EPS Next 2Y2.73%
EPS Next 3YN/A
BOI.PA Yearly Income VS Free CF VS DividendBOI.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
BOI.PA Dividend Payout.BOI.PA Dividend Payout, showing the Payout Ratio.BOI.PA Dividend Payout.PayoutRetained Earnings

BOI.PA Fundamentals: All Metrics, Ratios and Statistics

BOIRON SA

EPA:BOI (3/13/2026, 7:00:00 PM)

26

-0.25 (-0.95%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-06
Earnings (Next)04-02
Inst Owners5.47%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap456.30M
Revenue(TTM)504.86M
Net Income(TTM)19.37M
Analysts80
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.44%
Yearly Dividend1.35
Dividend Growth(5Y)-1.41%
DP107.57%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 23.21
Fwd PE 11.24
P/S 0.9
P/FCF 12.24
P/OCF 8.62
P/B 1.24
P/tB 1.83
EV/EBITDA 5.66
EPS(TTM)1.12
EY4.31%
EPS(NY)2.31
Fwd EY8.9%
FCF(TTM)2.12
FCFY8.17%
OCF(TTM)3.02
OCFY11.6%
SpS28.77
BVpS21.03
TBVpS14.24
PEG (NY)4.2
PEG (5Y)N/A
Graham Number23.02
Profitability
Industry RankSector Rank
ROA 3.45%
ROE 5.25%
ROCE 5.9%
ROIC 4.43%
ROICexc 5.25%
ROICexgc 7.65%
OM 5.26%
PM (TTM) 3.84%
GM 73.71%
FCFM 7.39%
ROA(3y)4.57%
ROA(5y)4.15%
ROE(3y)6.7%
ROE(5y)6.13%
ROIC(3y)5.61%
ROIC(5y)5.46%
ROICexc(3y)8.01%
ROICexc(5y)8.34%
ROICexgc(3y)11.86%
ROICexgc(5y)12.41%
ROCE(3y)7.49%
ROCE(5y)7.29%
ROICexgc growth 3Y-33.41%
ROICexgc growth 5Y-24.37%
ROICexc growth 3Y-32.4%
ROICexc growth 5Y-24.82%
OM growth 3Y-32.06%
OM growth 5Y-23.58%
PM growth 3Y-28.17%
PM growth 5Y-20.44%
GM growth 3Y0.74%
GM growth 5Y-0.95%
F-Score7
Asset Turnover0.9
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.49
Debt/EBITDA 0.2
Cap/Depr 35.13%
Cap/Sales 3.1%
Interest Coverage 30.02
Cash Conversion 74.49%
Profit Quality 192.52%
Current Ratio 2.39
Quick Ratio 1.46
Altman-Z 3.56
F-Score7
WACC8.12%
ROIC/WACC0.55
Cap/Depr(3y)71.98%
Cap/Depr(5y)71.7%
Cap/Sales(3y)3.47%
Cap/Sales(5y)3.78%
Profit Quality(3y)124.88%
Profit Quality(5y)120.26%
High Growth Momentum
Growth
EPS 1Y (TTM)-18.09%
EPS 3Y-26.29%
EPS 5Y-22.4%
EPS Q2Q%241.06%
EPS Next Y5.53%
EPS Next 2Y2.73%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.8%
Revenue growth 3Y2.32%
Revenue growth 5Y-2.63%
Sales Q2Q%7.58%
Revenue Next Year2.95%
Revenue Next 2Y1.47%
Revenue Next 3Y8.32%
Revenue Next 5Y5.54%
EBIT growth 1Y-11.18%
EBIT growth 3Y-30.48%
EBIT growth 5Y-25.59%
EBIT Next Year86.05%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y113.74%
FCF growth 3Y22.31%
FCF growth 5Y12.1%
OCF growth 1Y57.85%
OCF growth 3Y5.87%
OCF growth 5Y-4.91%

BOIRON SA / BOI.PA FAQ

Can you provide the ChartMill fundamental rating for BOIRON SA?

ChartMill assigns a fundamental rating of 5 / 10 to BOI.PA.


What is the valuation status of BOIRON SA (BOI.PA) stock?

ChartMill assigns a valuation rating of 5 / 10 to BOIRON SA (BOI.PA). This can be considered as Fairly Valued.


How profitable is BOIRON SA (BOI.PA) stock?

BOIRON SA (BOI.PA) has a profitability rating of 4 / 10.


Can you provide the PE and PB ratios for BOI stock?

The Price/Earnings (PE) ratio for BOIRON SA (BOI.PA) is 23.21 and the Price/Book (PB) ratio is 1.24.


Is the dividend of BOIRON SA sustainable?

The dividend rating of BOIRON SA (BOI.PA) is 5 / 10 and the dividend payout ratio is 107.57%.